A study on prevalence of obesity and menstrual disturbances in women with polycystic ovary syndrome

B. Thangabalan; D. Curie; Sambravu Padmasri; Tenali Keerthana; Doppa Lokesh

doi:10.18203/2320-1770.ijrcog20262092

Authors

B. Thangabalan Department of Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, India
D. Curie Department of Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, India
Sambravu Padmasri Department of Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, India
Tenali Keerthana Department of Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, India
Doppa Lokesh Department of Pharmacy, SIMS College of Pharmacy, Guntur, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262092

Keywords:

Polycystic ovary syndrome, Obesity, Menstrual cycle disturbances

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is often linked with obesity and menstrual irregularities.

Methods: A community based cross-sectional study was conducted among 300 women with PCOS using a structured questionnaire to collect demographic data, treatment status, weight factors and menstrual characteristics. BMI categorized participants as normal weight, overweight or obese and menstrual patterns such as irregular cycles, painful periods and heavy bleeding were recorded.

Results: The findings showed a high prevalence of overweight and obesity, with many participants experiencing menstrual disturbances.

Conclusions: A strong association was observed between higher BMI and increased menstrual irregularities, highlighting the importance of early diagnosis, lifestyle modification and weight management in improving reproductive health outcomes in women with PCOS.

Metrics

Metrics Loading ...

References

Shukla A, Rasquin LI, Anastasopoulou C. Polycystic ovarian syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2026.

Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883-96. DOI: https://doi.org/10.1038/sj.ijo.0801994

Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-37. DOI: https://doi.org/10.1093/humupd/dms030

Ganie MA, Chowdhury S, Malhotra N, Sahay R, Bhattacharya PK, Agrawal S, et al. Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Netw Open. 2024;7(10):e2440583.

Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022;14(12):e32351. DOI: https://doi.org/10.7759/cureus.32351

Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. DOI: https://doi.org/10.1038/nrdp.2016.57

Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223-7. DOI: https://doi.org/10.1016/j.jpag.2011.03.002

Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome. Hum Reprod. 2012;27(1):14-24. DOI: https://doi.org/10.1093/humrep/der396

Strelec M, Solter M, Buković D, Kopjar M. Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population. Coll Antropol. 2013;37(2):465-70.

Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathophysiology and management. Endocr Rev. 2019;40(3):1046-83. DOI: https://doi.org/10.1177/1179558119874042

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(12):4565-73.

Chen X, Li L, Chen Y, Wang Y, Zhang Y, Liu H, et al. Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2024;103(8):1606-14. DOI: https://doi.org/10.1111/aogs.14863

Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JSE, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487-525. DOI: https://doi.org/10.1210/er.2015-1018

Niranjani S, Prema K, Sahayarani G, Dinesh M, Carline K. Prevalence of polycystic ovarian syndrome among young college girls: a cross-sectional study. Cureus. 2025;17(9):e92623. DOI: https://doi.org/10.7759/cureus.92623

Moran LJ, Ko H, Misso ML, Marsh K, Noakes M, Talbot M, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Hum Reprod Update. 2013;19(5):432. DOI: https://doi.org/10.1093/humupd/dmt015